Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
about
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
description
im Juli 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 10 July 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2018
@uk
name
Analysis of Plasma Epstein-Bar ...... A Randomized Controlled Trial
@en
Analysis of Plasma Epstein-Bar ...... A Randomized Controlled Trial
@nl
type
label
Analysis of Plasma Epstein-Bar ...... A Randomized Controlled Trial
@en
Analysis of Plasma Epstein-Bar ...... A Randomized Controlled Trial
@nl
prefLabel
Analysis of Plasma Epstein-Bar ...... A Randomized Controlled Trial
@en
Analysis of Plasma Epstein-Bar ...... A Randomized Controlled Trial
@nl
P2093
P50
P356
P1476
Analysis of Plasma Epstein-Bar ...... A Randomized Controlled Trial
@en
P2093
Anthony T C Chan
Ashley C K Cheng
Darren M C Poon
Edwin P Hui
Frank C S Wong
Frankie Mo
Hoi C Cheng
K C Allen Chan
P304
JCO2018777847
P356
10.1200/JCO.2018.77.7847
P407
P50
P577
2018-07-10T00:00:00Z